Innovations for Next-Generation Antibody-Drug Conjugates

Du sparer 0% ift. normalprisen Spar 0%

Paperback
8-11 hverdage
1.687,95 kr.

Bag om Innovations for Next-Generation Antibody-Drug Conjugates

While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.

Vis mere

Sprog:
Engelsk

ISBN:
9783030086275

Forlag:
Springer Nature Switzerland AG

Indbinding:
Paperback

Sideantal:
357

Udgivet:
8. februar 2019

Udgave:
12018

Størrelse:
155x235x0 mm.

Vægt:
563 g.

Leveringstid: 8-11 hverdage.
Forventet levering: 7. december 2024

På lager

Normalpris

1.687,95 kr. + Fragt
~~1.686,95 kr.~~

Abonnementspris

1.682,95 kr.

- Rabat på køb af fysiske bøger
- 1 valgfrit digitalt ugeblad
- 20 timers lytning og læsning
- Adgang til 70.000+ titler
- Ingen binding

Abonnementet koster 75 kr./md.
Ingen binding og kan opsiges når som helst.

Beskrivelse af Innovations for Next-Generation Antibody-Drug Conjugates

While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.

Brugerbedømmelser af Innovations for Next-Generation Antibody-Drug Conjugates

Andre købte også..

Find lignende bøger

Bogen Innovations for Next-Generation Antibody-Drug Conjugates findes i følgende kategorier:

Business og læring